Plasma lipoprotein(a) ILp(a)I, a low density lipoprotein particle with an attached apolipoprotein(a) Iapo(a)J, varies widely in concentration between individuals. These concentration differences are heritable and inversely related to the number of kringle 4 repeats in the apo(a) gene. To define the genetic determinants of plasma Lp(a) levels, plasma Lp(a) concentrations and apo(a) genotypes were examined in 48 nuclear Caucasian families. Apo(a) genotypes were determined using a newly developed pulsed-field gel electrophoresis method which distinguished 19 different genotypes at the apo(a) locus. The apo(a) gene itself was found to account for virtually all the genetic variability in plasma Lp(a) levels. This conclusion was reached by analyzing plasma Lp(a) levels in siblings who shared zero, one, or two apo(a) genes that were identical by descent (ibd). Siblings with both apo(a) alleles ibd (n = 72) have strikingly similar plasma Lp(a) levels (r = 0.95), whereas those who shared no apo(a) alleles (n = 52), had dissimilar concentrations (r = -0.23). The apo(a) gene was estimated to be responsible for 91% of the variance of plasma Lp(a) concentration. The number of kringle 4 repeats in the apo(a) gene accounted for 69% of the variation, and yet to be defined cis-acting sequences at the apo(a) locus accounted for the remaining 22% of the inter-individual variation in plasma Lp(a) Plasma concentrations of Lp(a) vary over a wide range among individuals, but are remarkably stable in any given individual (10). Many physiological, pharmacological, and environmental factors that affect the levels ofother plasma lipoproteins have no effect on the plasma concentration of Lp(a) (10). This lack of environmental and physiological influences suggests that plasma Lp(a) levels are largely genetically determined. Consistent with this formulation, early genetic studies suggested that the presence ofLp(a) in plasma was inherited as an autosomal dominant trait (1 1-13). When more sensitive immunoassays of plasma Lp(a) concentrations were used, it was found that plasma Lp(a) concentrations varied continuously among individuals ( 14), and the pattern of inheritance indicated that a major gene, as well as polygenic factors, contributed to plasma Lp(a) concentrations (15) (16) (17) .
Introduction
Lipoprotein(a) [Lp(a)]' is a cholesterol ester-rich plasma lipoprotein comprising two attached components: a low density lipoprotein (LDL) particle and a single large glycoprotein, apolipoprotein(a) [apo(a)] (1-3). High plasma levels of Lp(a) are associated with the development of coronary atherosclerosis (4) (5) (6) and other vascular diseases (7) . The mechanism by which Lp(a) expedites the atherosclerotic process is not known. Apo(a) strongly resembles plasminogen, and it may Plasma concentrations of Lp(a) vary over a wide range among individuals, but are remarkably stable in any given individual (10) . Many physiological, pharmacological, and environmental factors that affect the levels ofother plasma lipoproteins have no effect on the plasma concentration of Lp(a) (10) . This lack of environmental and physiological influences suggests that plasma Lp(a) levels are largely genetically determined. Consistent with this formulation, early genetic studies suggested that the presence ofLp(a) in plasma was inherited as an autosomal dominant trait (1 1-13) . When more sensitive immunoassays of plasma Lp(a) concentrations were used, it was found that plasma Lp(a) concentrations varied continuously among individuals ( 14) , and the pattern of inheritance indicated that a major gene, as well as polygenic factors, contributed to plasma Lp(a) concentrations (15) (16) (17) .
Fless et al. ( 18) and Utermann et al. (19) found that the apo(a) glycoprotein varied in size among individuals. In an important series of studies, Utermann and his colleagues demonstrated that the size ofthe apo(a) protein is inversely related to the level of plasma Lp(a), thus implicating the apo(a) gene as a major determinant of plasma Lp(a) concentrations (20) (21) (22) (23) . However, the immunoblotting technique used to type the apo(a) isoforms was not sensitive enough to detect low levels of apo(a) protein, and not all of the apo(a) isoforms were detected. As a result, the frequency distribution of the apo(a) isoforms failed to fit the expectations ofHardy-Weinberg equilibrium (22) . In addition, when immunoblotting was employed to examine the segregation of the apo(a) isoforms in families, the results were frequently uninformative, and occasionally inconsistent (24) . Further progress required the development of a technique that was more discriminating than immunoblotting in classifying apo(a) alleles.
A potential method to study this polymorphism was suggested by the (25) . This hypothesis was supported by studies ofthe apo(a) mRNA and gene structure (26) (27) (28) . In attempt to devise a way to measure the size of the apo(a) gene in different individuals, we previously identified a large restriction fragment from the apo(a) gene which contains most, ifnot all, of the kringle 4-encoding sequences (29) . The (29) . However, individuals with the same apo(a) genotypes who were members of different families often had significantly different plasma concentrations of Lp(a). Taken together, these observations suggest that the apo(a) gene is the major determinant ofplasma Lp(a) levels and that cis-acting DNA sequences at or near the apo (a) locus, other than the number of kringle 4 repeats, contribute importantly to plasma Lp(a) concentrations.
In the current study, we analyzed the segregation of the apo(a) gene and Lp(a) levels in 48 Caucasian pedigrees to determine the contribution of the apo(a) gene (or closely linked loci) to the plasma concentrations ofLp(a). The genetic architecture (30) of plasma Lp( a) concentrations was defined at three levels: the polygenic heritability, the total genetic contribution ofthe apo(a) gene, and the effects of length variation in the apo (a) gene. In addition, we describe the de novo generation of a new apo(a) allele of different size within a family.
Methods
Subjects. Plasma Lp(a) concentrations were measured in a sample of 288 fasting individuals from 48 Caucasian American families living in the greater Dallas, Texas area. Families in which both parents and at least three children were available for sampling were selected for study. None of the families had evidence of a monogenic hyperlipidemia. In one family, F153, several members (who are denoted in Table II) had very low LDL-cholesterol levels, suggesting the possible existence of familial hypobetalipoproteinemia. For the random effects analysis of variance (see below), the families were augmented with a sample of 107 unrelated individuals. Preliminary findings on a subset of these unrelated individuals have been reported previously (29) .
Phlebotomy was carried out after an overnight fast. A total of 30 ml of blood was collected from each individual in vacutainer tubes containing sodium-EDTA. The plasma was separated within one hour of collection by centrifugation at 2,000 g for 15 min at 4VC. Multiple 50 ,d aliquots of plasma were stored at -70'C and Lp(a) levels were assayed within 4 wks.
Pulsed-field gel analysis of the apo(a) gene. A total of 15 ml of blood was maintained at room temperature prior to transfer to two LeucoPREP tubes (Becton, Dickinson & Co., Lincoln Park, NJ). Lymphocytes were isolated and embedded in agarose plugs as previously described (29) . The agarose-cellular plugs were incubated twice with 40 U ofKpnI in 170 ul ofthe buffer suggested by the manufacturer (New England Biolabs, Beverly, MA). The digested cellular-agarose plugs were subjected to pulsed-field gel electrophoresis in a vertical submarine gel apparatus with a transverse alternating field (Geneline I, Beckman Instruments, Inc., Fullerton, CA) using low-endosmosis coefficient agarose, TAFE buffer, and X phage concatamer standards (Beckman Instruments, Inc.) as described by Lackner et al. (29) . After (33) .
Statistical methods. The distribution of plasma Lp(a) concentration was positively skewed in these data, and thus all analyses were carried out both on the raw and square-root transformed data. For each analysis, the primary inferences were identical whether the raw or transformed data was used.
The contribution of unmeasured polygenic variation to the inter-individual variability of plasma Lp(a) concentrations (ap(a)2) was assessed from the extent of familial aggregation of Lp(a) levels in the sample of pedigrees. The ratio of the polygenic variance component (apg2) to aLp(a)2 was estimated by maximum likelihood principles as implemented in the computer program PAP V3.0 (34).
Sibling-pair linkage methods were used to estimate the overall contribution of genetic variation in and around the apo(a) gene (Oapo(a)2) to plasma Lp(a) levels (35, 36 (30) show that: E(yj) = a +~r j + 7fj (1) ence between the Lp(a) levels of siblings who share none, one, or all apo(a) alleles ibd. The regression analyses were performed both unweighted and weighted, as suggested by Amos et al. (36) , with nearly identical results. Therefore, only the results ofthe unweighted analyses are presented. Even though the sibships were typically larger then size two, the above method has been shown to be valid when overlapping sibling pairs are analyzed as though they were independent (36).
The contribution of length variation in the apo(a) gene, as measured by pulsed-field gel electrophoresis, to Lp(a) concentrations, a ,egff2, was estimated using a random effects analysis ofvariance (37).
A random effects or type II model was selected because of the large number of potential genotypes at the apo(a) locus (38) .
Results
Plasma Lp(a) concentrations were measured in 288 individuals from 48 pedigrees. There was no significant effect of age, sex, or the concentration of other plasma lipoproteins on the plasma level of Lp(a), so these factors were not considered further in the family members (data not shown). There were significant correlations between the plasma Lp(a) levels ofparents and offspring (r = 0.44), and siblings (r = 0.28), but not between spouses (r = 0.17) ( Table 1) . By using standard biometrical genetic analyses, it was estimated that 85% (±8%) of the inter-individual variance of Lp(a) concentrations was attributable to polygenic effects (apg2/ aLp(a)2) (or 88% (±6. 5) when the square-root of the plasma Lp(a) levels was used).
Pulsed-field gel electrophoresis and genomic blotting of KpnI digested-genomic DNA was performed to assess the size of the kringle 4-encoding region of the apo(a) alleles in each family member. 16 of the 19 previously described apo(a) alleles were observed in the sample, and their frequencies did not differ significantly from those previously described from the same population (29) . In general, there was an inverse relationship between the size of the apo(a) allele and the plasma level of Lp(a). One way to illustrate this phenomenon is to examine the relationship between the plasma Lp(a) concentrations and the apo(a) allele size in the individuals who had one of the two most common alleles, apo(a) 14 or apo(a) 15 plus a different allele (Fig. 1) . Individuals with one copy ofapo(a) 14 or apo(a) 15 plus one copy ofapo(a)2-apo(a)4 tended to have high plasma Lp(a) levels (> 30 mg/dl). If the second allele was apo(a)S-apo(a) 7, the Lp(a) levels were lower (15-30 mg/ dl). If the second allele was larger than apo(a) 8, the plasma concentrations of Lp(a) were low [< 10 mg/dl, excluding apo(a) 10] .
In the population as a whole, different apo(a) genotypes, as determined by pulsed-field gel electrophoresis, were associated with significantly different plasma levels of Lp(a) (P < 0.001 for both the raw and transformed data). A random effects analysis of variance (37) Fig. 2 shows two pedigrees in which an apo(a) allele ofthe same size, apo(a)6, segregates. In the two pedigrees this allele gives rise to very different plasma concentrations of Lp(a). In A, the apo(a)6 allele ofthe father (a), is inherited by three of his offspring (c, d, and f). The father, as well as the three offspring, have modest plasma Lp(a) concentrations (6 mg/dl, and 7, 5, and 3 mg/dl, respectively). In the family shown in B, individual h, who is also heterozygous for an allele the size of apo(a)6, and has a high plasma Lp(a) concentration (51 mg/dl). Of her four children, only the second child (j) inherited apo(a)6 and she is the only offspring with a comparable plasma level of Lp(a) (51 mg/dl). Therefore, in these two families, the same sized apo(a) allele (apo(a)6) segregated with very different plasma levels of Lp(a). This was true even though the other alleles at the apo(a) locus in the families were similar (apo(a) 13- apo(a) 17). These findings suggest that factors at the apo(a) Fig. 3 . In this family, the mother (b) is 48 families, all four parental apo(a) alleles could be differenhomozygous for apo(a) 12 , so all of the children (c-f) are het-tiated using pulsed-field gel electrophoresis. In six families (inerozygous for that allele. Based on the genomic blot, it cannot cluding the one shown in Fig. 3 ), the length polymorphism was be determined which of the two apo(a) 12 Only offspring e has a band the same size as the isoform of the were selected at random, so in some families all the plasma mother. This suggests that the mother is heterozygous and has concentrations of Lp(a) were low (i.e., <5 mg/dl) reflecting one apo(a) 12 that produces no detectable circulating apo(a) the highly skewed distribution of plasma Lp(a) levels in the protein which she gave to c, d, and fand another that is asso-Caucasian population. ciated with the production of a moderate amount of apo(a) Genetic Determinants of Plasma Lipoprotein(a) 55 The dominance deviations at the apo(a) locus ('y) was not ibd is graphically presented in Fig. 5 . The average squared dif- (Fig. 6) . The fourth child, individualf, has apo(a) 16 and apo(a) 9 . Clearly, he inherited apo(a) 16 from his mother, but his father does not have apo(a) 9 . Paternity testing was performed using 7 unlinked varying number oftandem repeat (VNTRs), and in each case, the genotype of individual f was consistent with individual f being the child of individual a (39) . The calculated probability of individual a not being the true father was < 1 x 10-6 (data not shown). Therefore, a mutation must have occurred in a paternal gamete which resulted in the generation of an apo (a) allele of different size.
Discussion
In this article we have evaluated the segregation of the apo(a) gene and plasma Lp(a) levels in 48 Caucasian families and found that virtually all the inter-individual variation in plasma Lp(a) levels was attributable to the genomic region encoding the apo(a) glycoprotein. It had been clear from previous family studies that plasma Lp(a) levels are largely genetically determined; prior estimates of the heritability of plasma Lp(a) levels have ranged from 0.75 to 0.98 (15, 17, 40, 41) which is comparable to our estimate of 0.85 (±8%). Initially, Lp(a) could only be detected in the plasma of Lp(a) of a third of individuals, and yet when family studies were performed, the inheritance pattern suggested a single autosomal dominant gene (1 1-13, [42] [43] [44] . When more sensitive radioimmunoas- Lp(a) and his colleagues estimated that differences in apo(a) glycoprotein accounted for 41% of inter-individual plasma Lp(a) levels (22 Lp(a) 1 Lp(a) concentrations and DNA sequences in the plasminogen gene which is closely linked to the apo(a) gene (45, 46) .
The present study is distinguished from prior family studies by the fact that the apo(a) gene, rather than the expressed protein, was examined in relation to the level of Lp(a) plasma. In prior studies the immunoblotting techniques tudes higher than the usual bi-allelic DNA sequence polymorphisms (39, 51) . Given the large number of different sized alleles at the apo(a) locus, a relatively high mutation rate was expected. Therefore, it was anticipated that mutations in the gene would be identified if a sufficient number of families were analyzed. We have observed one mutation of an apo(a) allele out of a total of 376 meioses, and this rate is of the same order of magnitude as the frequency of newly generated alleles for VNTR sequences (39, 51 ) .
Most length polymorphisms in the human genome involve noncoding sequences. The coding regions of several mammalian genes have short tandem repeats (i.e., less the 50 basepairs) which are polymorphic in length (52) (53) (54) (55) (56) . There are also examples of entire genes being tandemly repeated, as is the case with rDNA, 5S DNA, and the histone genes. The apo(a) length polymorphism is distinguished by the fact that the repeated sequence is large (5.5 kb) and contains both coding and noncoding sequences. The polyubiquitin gene (UbC), contains a large length polymorphism within its coding sequence, but all of the repeated sequences are contained in one exon, and each of the seven to nine repeats encodes the entire protein (57) . The heterozygosity index of this length polymorphism is low (22%) compared to the apo(a) gene (94%). The extremely high degree of heterozygosity at the apo(a) locus may reflect the fact that it is under less selective pressure. A physiological function for this enigmatic protein has yet to be identified (2) . Alternatively, there may be something intrinsic to the kringle 4-encoding sequences which make them more susceptible to recombinational events.
Mutations ofrepeated sequence domains result from either intrachromosomal or interchromosomal events. Initially, it was proposed that the mechanism primarily responsible for the high degree ofsize polymorphism in VNTRs was due to homologous recombination and unequal exchange during meiosis. However, molecular analysis of several new mutations revealed no exchange of flanking genetic markers, which suggests that intrachromosomal, rather than interchromosomal, events appear to be predominantly responsible (51, 58) . Similarly, recent molecular analysis of tandem duplication within the Duchenne muscular dystrophy gene demonstrated that the recombinational events were due to intrachromosomal unequal exchange between sister chromatids rather than involving homologous chromosomes (59, 60) . Efforts are now being directed to identify polymorphisms flanking the apo(a) gene to analyze the nature of the mutational event(s) responsible for the observed size heterogeneity at the apo(a) locus.
